These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 6818043

  • 21. The effects of pertussis toxin on autoreceptor-mediated inhibition of dopamine synthesis in the rat striatum.
    Bean AJ, Shepard PD, Bunney BS, Nestler EJ, Roth RH.
    Mol Pharmacol; 1988 Dec; 34(6):715-8. PubMed ID: 2974120
    [Abstract] [Full Text] [Related]

  • 22. Demonstration of autoreceptors on dopamine neurons in different brain regions of rats treated with gammabutyrolactone.
    Andén NE, Grabowska-Andén M, Liljenberg B.
    J Neural Transm; 1983 Dec; 58(3-4):143-52. PubMed ID: 6420514
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Attenuation of the gamma-butyrolactone-induced increase in DOPA accumulation by chronic ethanol administration.
    Liljequist S, Engel J.
    J Neural Transm; 1979 Dec; 46(3):195-204. PubMed ID: 528994
    [Abstract] [Full Text] [Related]

  • 27. D1 dopamine receptor stimulation enables the postsynaptic, but not autoreceptor, effects of D2 dopamine agonists in nigrostriatal and mesoaccumbens dopamine systems.
    Wachtel SR, Hu XT, Galloway MP, White FJ.
    Synapse; 1989 Dec; 4(4):327-46. PubMed ID: 2532422
    [Abstract] [Full Text] [Related]

  • 28. 7-[3-(4-[2,3-Dimethylphenyl]piperazinyl)propoxy]-2(1H)-quinolinone (OPC-4392), a presynaptic dopamine autoreceptor agonist and postsynaptic D2 receptor antagonist.
    Yasuda Y, Kikuchi T, Suzuki S, Tsutsui M, Yamada K, Hiyama T.
    Life Sci; 1988 Dec; 42(20):1941-54. PubMed ID: 3130534
    [Abstract] [Full Text] [Related]

  • 29. Relationship between receptor occupancy and response at striatal dopamine autoreceptors.
    Meller E, Bohmaker K, Namba Y, Friedhoff AJ, Goldstein M.
    Mol Pharmacol; 1987 Jun; 31(6):592-8. PubMed ID: 2885734
    [Abstract] [Full Text] [Related]

  • 30. Responsiveness to 'autoreceptor' doses of apomorphine inversely correlated with the firing rate of dopaminergic A9 neurons: action of baclofen.
    Mereu G, Muntoni F, Calabresi P, Romani F, Boi V, Gessa GL.
    Neurosci Lett; 1986 Apr 11; 65(2):161-6. PubMed ID: 3714103
    [Abstract] [Full Text] [Related]

  • 31. Evidence for dopamine autoreceptors in mesocortical dopamine neurons.
    Fadda F, Gessa GL, Marcou M, Mosca E, Rossetti Z.
    Brain Res; 1984 Feb 13; 293(1):67-72. PubMed ID: 6423212
    [Abstract] [Full Text] [Related]

  • 32. Relative selectivity of 6,7-dihydroxy-2-dimethylaminotetralin, N-n-propyl-3-(3-hydroxyphenyl)piperidine, N-n-propylnorapomorphine and pergolide as agonists at striatal dopamine autoreceptors and postsynaptic dopamine receptors.
    Claustre Y, Fage D, Zivkovic B, Scatton B.
    J Pharmacol Exp Ther; 1985 Feb 13; 232(2):519-25. PubMed ID: 2857197
    [Abstract] [Full Text] [Related]

  • 33. Increased striatal dopamine synthesis is associated with decreased tissue levels of tyrosine.
    Bongiovanni R, Young D, Newbould E, Jaskiw GE.
    Brain Res; 2006 Oct 18; 1115(1):26-36. PubMed ID: 16934236
    [Abstract] [Full Text] [Related]

  • 34. Increased site-specific phosphorylation of tyrosine hydroxylase accompanies stimulation of enzymatic activity induced by cessation of dopamine neuronal activity.
    Lew JY, Garcia-Espana A, Lee KY, Carr KD, Goldstein M, Haycock JW, Meller E.
    Mol Pharmacol; 1999 Feb 18; 55(2):202-9. PubMed ID: 9927609
    [Abstract] [Full Text] [Related]

  • 35. Chronic prenatal haloperidol exposure: lack of effect on presynaptic dopamine autoreceptors.
    Scalzo FM, Newport GD, Gough BJ, Ali SF, Holson RR.
    Neurotoxicology; 1989 Feb 18; 10(3):485-90. PubMed ID: 2516618
    [Abstract] [Full Text] [Related]

  • 36. Increase of dopamine synthesis in synaptosomes from rats treated with neuroleptics or reserpine.
    Tissari AH.
    Med Biol; 1982 Feb 18; 60(1):38-41. PubMed ID: 6121960
    [Abstract] [Full Text] [Related]

  • 37. Lack of effect of gamma-butyrolactone on amphetamine-induced decrease in striatal synaptosomal dopamine synthesis.
    Kuczenski R.
    J Neurochem; 1978 Jul 18; 31(1):347-9. PubMed ID: 671029
    [No Abstract] [Full Text] [Related]

  • 38. Action of beta(4-chlorphenyl)GABA, gamma-hydroxybutyrolactone, and apomorphine on central dopamine neurons.
    Fuxe K, Agnati L, Everitt BJ, Hökfelt T, Ljungdahl A, Perez de la Mora M.
    Adv Biochem Psychopharmacol; 1977 Jul 18; 16():489-94. PubMed ID: 883553
    [No Abstract] [Full Text] [Related]

  • 39. Alteration of striatal dopaminergic functions implicated in methamphetamine-induced reverse tolerance in rats.
    Kaneno S, Watanabe A, Takahashi R.
    Eur J Pharmacol; 1986 Apr 16; 123(2):287-94. PubMed ID: 3086109
    [Abstract] [Full Text] [Related]

  • 40. Tyrosine availability and dopamine synthesis in the striatum: studies with gamma-butyrolactone.
    Sved A, Fernstrom J.
    Life Sci; 1981 Aug 17; 29(7):743-8. PubMed ID: 6792441
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.